News

New World Angels Press Releases and Updates

Posts tagged corneal disease treatment

New World Angels Invests in Epion Therapeutics

New World Angels Invests in Epion Therapeutics

New World Angels invests $425K in Epion Therapeutics to support its FDA-bound treatment for corneal diseases using EpiSmart™ technology.

PressAdriana SalcedoOctober 9, 2025investment, Startup Funding, Biotech investment, Venture Captial, HealthTech, Startup News, biotechnology, pharmaceuticals, life sciences, healthcare innovations, medical startups, seed funding, corneal disease treatment